Clinical Trial Update: Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL [Phase 2, Phase 3]

View source ↗

Summary

This document reports a planned Phase 2/3 clinical trial evaluating Orelabrutinib combined with teniposide, rituximab, and methotrexate for newly diagnosed prim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Orelabrutinib (orelabrutinib)
• Rituximab (rituximab)
• Teniposide (teniposide)

Snippet

Sponsor: Huashan Hospital | Conditions: Primary Central Nervous System Lymphoma | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING